ARENA PHARMACEUTICALS INC's ticker is ARNAXXXX and the CUSIP is 040047102. A total of 130 filers reported holding ARENA PHARMACEUTICALS INC in Q2 2015. The put-call ratio across all filers is 0.72 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2015 | $9,000 | +28.6% | 2,000 | 0.0% | 0.01% | +20.0% |
Q4 2014 | $7,000 | -12.5% | 2,000 | 0.0% | 0.01% | -16.7% |
Q3 2014 | $8,000 | -27.3% | 2,000 | 0.0% | 0.01% | -25.0% |
Q2 2014 | $11,000 | -15.4% | 2,000 | 0.0% | 0.01% | -27.3% |
Q1 2014 | $13,000 | +8.3% | 2,000 | 0.0% | 0.01% | +10.0% |
Q4 2013 | $12,000 | – | 2,000 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SENZAR ASSET MANAGEMENT, LLC | 1,952,891 | $2,852,000 | 0.72% |
Nine Chapters Capital Management LLC | 180,200 | $263,000 | 0.36% |
Camber Capital Management LP | 4,250,000 | $6,205,000 | 0.25% |
TFS CAPITAL LLC | 340,092 | $497,000 | 0.16% |
ASCEND CAPITAL, LLC | 1,008,949 | $1,473,000 | 0.07% |
Acrospire Investment Management LLC | 39,781 | $58,000 | 0.05% |
OXFORD ASSET MANAGEMENT LLP | 1,081,912 | $1,580,000 | 0.04% |
Jacobi Capital Management LLC | 35,000 | $49,000 | 0.02% |
Renaissance Technologies | 8,479,445 | $12,380,000 | 0.02% |
A.R.T. Advisors, LLC | 238,036 | $347,000 | 0.02% |